Objective: The vasoconstrictor angiotensin II (Ang II) acts at G q/11 -coupled receptors to suppress ATP-sensitive potassium (K ATP ) channel activity via activation of protein kinase C (PKC). The aim of this study was to determine the PKC isoforms involved in the Ang II-induced inhibition of aortic K ATP channel activity and to investigate potential mechanisms by which these isoforms specifically target these ion channels.
Introduction
Angiotensin II (Ang II) is a potent endogenous vasoconstrictor that elicits contraction of vascular smooth muscle via multiple pathways including enhanced Ca 2+ influx across the sarcolemma, release of Ca 2+ from intracellular stores and sensitization of the contractile machinery to Ca 2+ [1] . Enhanced Ca 2+ influx occurs via direct activation of Ca 2+ -permeable channels as well as indirect voltage-dependent elevation of Ca 2+ channel activity through membrane depolarization [2] [3] [4] . Ang II has been shown to depolarize vascular smooth muscle via the activation of non-selective inward cation currents [5] , or the suppression of outward currents mediated by large conductance Ca 2+ -activated K + channels [6, 7] , voltage-dependent K + channels [8, 9] or ATPsensitive K + (K ATP ) channels [10, 11] . Arterial K ATP channels are known to be important regulators of membrane potential and thus vascular tone at rest and in response to vasoactive transmitters [12] [13] [14] . Functional studies in animals and man highlight the role of K ATP channels in regulating blood flow, with blockade of K ATP channels increasing vascular resistance in the systemic and coronary circulations, and K ATP channel activity contributing substantially to changes in vasomotor tone and blood flow in response to exercise [15] [16] [17] . Ang II, endothelin, noradrenaline, histamine and serotonin (5HT 2 ) act at G q/11 -coupled receptors to inhibit K ATP channels via activation of protein kinase C (PKC) [10, [18] [19] [20] . While this is believed to be an important regulatory mechanism, the PKC isoforms involved and the mechanism/s by which PKC targets K ATP channels are poorly understood. The 12 closely related isoenzymes that make up the PKC family share extensive structural homology and show limited substrate specificity in vitro [21] . Within the cell however, PKC isozymes mediate unique cellular functions by phosphorylating specific subsets of target proteins. Such substrate specificity is most likely conferred by differential targeting of activated PKC isoforms to distinct subcellular locations governed by the distribution of their preferred substrate [22] [23] [24] . We have shown recently that vascular K ATP channels localize primarily to small vesicular invaginations of the plasma membrane termed caveolae [25] . These specialized lipid microdomains comprise approximately 20% of the smooth muscle cell's total surface area and may act to generate subcellular signalling compartments by recruiting interacting signalling proteins [26] [27] [28] [29] . Indeed, caveolae have been identified as potential focal points for PKC signalling, with receptor-driven loss [29] or recruitment [30] of PKC isoforms to these distinct membrane regions. Here we use a combination of electrophysiological, biochemical and electron microscopy techniques to investigate whether Ang II induces the recruitment of specific PKC isoforms to smooth muscle caveolae to modulate K ATP channel activity.
Methods

Animals
Thoracic aorta was obtained from adult male Wistar rats (∼200 g) killed by stunning and rapid cervical dislocation. The investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996).
Antibodies, polyacrylamide gel electrophoresis and immunoblotting
The following primary antibodies were used: anti-PKCα, β, γ, δ, ε, ι/λ, anti-caveolin (BD Transduction Laboratories), anti-PKCθ (sc-212), anti-Kir6.1 (R-14; sc-11224) (Santa Cruz Biotechnology Inc), anti-transferrin receptor (Zymed Laboratories Inc), anti-smooth muscle α-actin (SigmaAldrich). Horseradish peroxidise (HRP)-conjugated secondary antibodies were all from Jackson Immunochemical Laboratories with the exception of HRP-conjugated antigoat which was from Sigma-Aldrich. Gold-conjugated secondary antibodies for use in immunogold electron microscopy were from British Biocell International. Protein extracts were resolved by SDS-polyacrylamide gel electrophoresis on 12% polyacrylamide-Tris gels and transferred electrophoretically onto nitrocellulose membranes (Hybond ECL, Amersham Pharmacia Biotech). Immunoblotting was carried out as described previously [31] .
Membrane fractionation
Rat thoracic aortae were incubated in the presence and absence of phorbol 12-myristate-13-acetate (PMA; 300 nM; 30 min, room temperature). Stimulated tissues were transferred to ice-cold lysis buffer (mM: 25 Tris, 250 NaCl, 3 EDTA, 1% Triton X-100) and disrupted rapidly in a handheld homogenizer. Lysed samples were spun in a Beckman bench-top ultracentrifuge (30,000 rpm, 30 min) and samples from soluble and particulate fractions analysed by SDSpolyacrylamide gel electrophoresis and immunoblotting.
Fractionation of caveolin-enriched membrane and assay for cholesterol
Buoyant caveolae-enriched membrane fractions were isolated under detergent-free conditions from rat aortic smooth muscle cell homogenates by ultracentrifugation on discontinuous sucrose gradients using a method adapted from [32] as previously described [25] . Cholesterol levels in each fraction collected from the gradient were determined by analysis with the Amplex Red cholesterol assay kit (Molecular Probes) according to the manufacturer's protocol.
Electron microscopy of immunogold-labelled smooth muscle plasma membrane sheets
Plasma membrane sheets from cultured aortic smooth muscle cells (2-4 days in primary culture) were prepared, fixed and labelled with primary and gold-conjugated secondary antibodies as previously described [33] . Membrane sheets were subsequently imaged using a FEI 120 kV Tecnai G 2 Spirit BioTWIN transmission electron microscope. NIH ImageJ software was used to measure distances between gold particles. Macros within ImageJ were also used to simulate random particle distributions on EM images.
Electrophysiology
Whole-cell K + currents were recorded from freshly dissociated rat aortic smooth muscle cells using an Axopatch 200B amplifier (Axon Instruments) as previously described [25] [19] [20] [21] [22] [23] [24] [25] [26] [27] and PKCε translocation inhibitor peptide were from Calbiochem. Experiments were conducted in a temperature-controlled bath at 25°C. Results are expressed as means ± S.E.M. Statistical significance was evaluated using ANOVA followed by Tukey-Kramer multicomparison test (StatsDirect, Cheshire, UK).
Results
We have shown previously that Ang II inhibits K ATP channels in rat mesenteric artery via a dual mechanism involving the inhibition of cAMP-dependent protein kinase (PKA) and the activation of PKC [11] . To establish that PKC is similarly involved in the modulation of K ATP currents in rat aorta (a preparation more amenable to biochemical analysis due to the relatively large amounts of tissue it yields), we assessed the effect of Ang II on pinacidil-evoked whole-cell K ATP current in the presence of specific and nonspecific PKC inhibitors. These experiments were conducted in the presence of 100 μM of the PKA inhibitor Rp-cAMPS to remove any complicating effects of vasoconstrictor inhibition of PKA. Under control conditions, the addition of 100 nM Ang II caused a 30.6 ± 3.3% inhibition (mean ± SEM; n = 6) of whole-cell current induced by the K ATP channel opener pinacidil in cells isolated from rat aortic artery (Fig. 1A, D insensitive to inhibition by Ang II (Ang II inhibition 1.4 ± 1.1%, n = 6, p b 0.0001, Fig. 1C, D) . This suggests that the novel PKC isoform, PKCε, is primarily involved in Ang IIinduced inhibition of aortic K ATP channels. To allow dialysis of the PKCε inhibitor peptide into cells these experiments were conducted in the conventional whole-cell recording configuration with intracellular Ca 2+ buffered by the presence of 10 mM EGTA. These recording conditions ([Ca 2+ ] i b 20 nM) could potentially inhibit the activity of the Ca 2+ -sensitive PKC isoforms (α, β and γ) leading to an underestimation of their involvement in channel inhibition [34] . We therefore undertook perforated patch experiments (which allow receptor-driven changes in intracellular Ca 2+ ) to assess the involvement of these conventional isoforms in Ang II-induced channel modulation. In perforated patch recordings, the presence of 1 μM of the conventional PKC isoform inhibitor Gö6976 had no effect upon the ability of Ang II to inhibit whole-cell pinacidil-induced currents (control Ang II inhibition 34.8 ± 5.1%; Ang II inhibition in the presence of Gö6976 36.0 ± 2.9%, n = 6, 6, Fig. 2A , B, C). These findings indicate that PKC-dependent inhibition of aortic K ATP channels by Ang II arises exclusively from the activation and translocation of PKCε.
To confirm our functional data, we investigated the expression and translocation properties of PKC isoforms in aortic smooth muscle. Typically the PKC isoenzymes α, β, δ, ε and ζ coexist in systemic vascular smooth muscle, although expression patterns vary depending upon species and vascular bed [35] . Using Western blot analysis of tissue homogenates we were able to detect all of these isoforms in rat aorta with the exception of PKCζ, which we were unable to identify conclusively with our range of antibodies (Fig. 3A) . Of the conventional, Ca 2+ -and DAG-sensitive isoforms, PKCα and low levels of PKCβ were present. Of the DAG-sensitive but Ca 2+ -insensitive novel isoforms we detected robust signals for PKCδ and ε and also the skeletal muscle isoform PKCθ, which has been reported in airways [36, 37] and cultured porcine aortic smooth muscle [38] . Additionally, we saw a strong expression of the atypical Ca 2+ -and DAG-insensitive PKCι/λ isoform, which has also previously been identified in pulmonary [39] , colonic circular [40] and cultured porcine aortic smooth muscle [38] .
Translocation to different cellular compartments enables PKC to colocalize with both activators and substrates. We thus assessed the ability of the strongly expressed aortic PKC isoforms to migrate to bulk membrane fractions in response to activation by the tumour-promoting phorbol ester, phorbal-12-myristate-13-acetate (PMA). Western blot analysis of cytosolic and membrane fractions separated by highspeed centrifugation of rat aortic smooth muscle cells showed a marked redistribution of PKCα, δ and ε from cytosol to membrane following stimulation by PMA (300 nM; Fig. 3B ). The cellular distribution of DAG (and hence phorbol ester)-insensitive isoforms PKCι/λ was unchanged by exposure to PMA. Fig. 4 . A, Western blot analysis of each of five 2 ml fractions collected from the top to the bottom of a discontinuous sucrose density gradient to determine the distribution of the caveolae-marker, caveolin-1 (top panel) and the non-caveolar transferrin receptor (lower panel). B, Relative cholesterol levels in each of five 2 ml fractions shown in A above. C, Exposure to 300 nM PMA induces a marked shift in the distribution of PKCα, δ and ε from the lower layers of the sucrose gradient to the buoyant caveolinenriched fractions. Treatment with 4α-PMA, an inactive isoform of PMA, had no effect on the distribution of PKC isoforms within the sucrose gradient. Since vascular K ATP channels localize primarily to caveolae [25] , we would predict that isoforms that modulate channel activity, such as PKCε, would specifically target these membrane compartments. The cholesterol and sphingolipid-enriched composition of caveolae gives them distinct biochemical properties-namely a highly reduced 'buoyant' density -that allows them to be separated from the bulk of the plasma membrane. We isolated buoyant membrane fractions under detergent-free conditions from rat aortic smooth muscle cell homogenates by ultracentrifugation on discontinuous sucrose gradients [25] . To assess the purity of caveolar and non-caveolar fractions, we used Western blot analysis to determine the distribution of specific caveolar and non-caveolar marker proteins and an assay to determine the level of cholesterol within each fraction. Western blot analysis of five 2 ml fractions collected from top to bottom of the sucrose density gradient showed the caveolae-specific protein caveolin-1 predominantly in fraction 2 (Fig. 4A) , suggesting this represents the buoyant caveolae-containing layer. Consistent with this, cholesterol was high in upper fractions 1 and 2 (Fig. 4B) . In contrast, transferrin receptor, a plasma membrane protein that is excluded from caveolae, localized to the low-cholesterol layers 3 and 4 of the gradient (Fig. 4A) . Under non-stimulated control conditions, the majority of PKC was confined to the lower layers of the gradient, which correspond to both non-caveolar membrane and cytosolic fractions (Fig. 4C) . A small proportion of PKCα and ε was associated with the caveolar layer at rest, while PKCδ and ι/λ were largely excluded from these buoyant upper fractions. Exposure to 300 nM PMA induced a significant shift in the distribution of both PKCα and ε from the lower layers of the sucrose gradient to the caveolinenriched membrane fractions. We observed a smaller shift in the distribution of PKCδ, but saw essentially no change in the distribution of the phorbol-insensitive ι/λ isoforms (Fig. 4C, lower panels) . Treatment with 4α-PMA, an inactive isoform of PMA, had no effect on the PKC distribution within the sucrose gradient.
To assess the effects of a physiological vasoconstrictor we repeated the above experiments in the presence and absence of Ang II. Western blot analysis revealed a significant shift in the distribution of both PKCα and PKCε from the lower layers of the sucrose gradient to the buoyant caveolinenriched fractions following exposure to 300 nM Ang II (Fig. 5A, B) . These upper layers also contain the poreforming subunit of the K ATP channel, which we have previously shown coimmunoprecipitates with the caveolaespecific protein caveolin [25] . In contrast, there was no statistically significant Ang II-induced movement of either PKCδ or PKCι/λ to caveolae.
To verify the location of K ATP channels within caveolae and the Ang II-induced migration of PKCε to these membrane microdomains we undertook immunogold electron microscopy. Aortic smooth muscle cells were plated onto poly-L-lysinecoated coverslips and allowed to adhere and grow to approximately 70% confluence. Plasma membrane sheets were ripped off these adherent cells directly onto EM grids as previously described [33] . The membrane sheets were fixed, labelled with primary antibodies (against Kir6.1 and/or caveolin, or PKCε and caveolin) and the location of these proteins visualized by the addition of appropriate secondary antibodies conjugated with gold particles of either 5 or 10 nm. Fig. 6A shows a transmission electron microscope (TEM) image of an aortic smooth muscle cell membrane sheet.
Caveolae are identifiable as 'donut-shaped' circular structures clustered in a line running horizontally across the centre of the image. Labelling of the membrane sheet with antibodies against the caveolae-marker caveolin confirms these structures as caveolae (Fig. 6B) . By co-staining the membrane sheets with antibodies against caveolin and Kir6.1, the pore-forming subunit of vascular K ATP channels, we were able to visualize K ATP channels within these membrane compartments (Fig. 6C) . Measurement of the distance between gold particles corresponding to Kir6.1 (5 nm) and gold particles corresponding to caveolin (10 nm) was used to quantify the association of these proteins. Our results indicate that approximately 70% of Kir6.1 particles are found within 50 nm of caveolin particles ( Fig. 6D ; 67.8 ± 3.1%; 1065 measurements made over 14 separate images). To assess the significance of this distribution we looked at what would be expected if Kir6.1 particles were randomly distributed. In simulated random distributions of approximately the same number of particles over the same images only 6.7 ± 2.4% of particles were found to be within 50 nm of caveolin (933 measurements of randomly generated particles over 14 separate images, p b 0.0001). Importantly, in control experiments no labelling was observed if the secondary antibodies were applied alone, and no cross-reactivity was seen with any of the secondary antibodies. These data therefore support our previous findings that vascular K ATP channels localize to smooth muscle caveolae [25] . To confirm that Ang II induces the recruitment PKCε to these membrane microdomains we labelled membrane sheets with antibodies against both PKCε and caveolin under control conditions and following stimulation with Ang II. In unstimulated control experiments we saw limited co-localization of PKCε and caveolin particles, with only 11.0 ± 3.0% of PKC within 50 nm of caveolin (Fig. 6E i; 223 measurements made over 9 separate images). Membrane sheets ripped from cells that had been preincubated with 300 nM Ang II however exhibited a marked change in PKCε distribution with 34.8 ± 3.7% of PKCε particles found within 50 nm (Fig. 6E ii; 210 measurements made over 11 separate images, p b 0.0005), and clear labelling of morphologically identifiable caveolae with PKCε ( Fig. 6E ii inset) .
Discussion
In this study we set out to determine the PKC isoforms involved in the Ang II-induced inhibition of aortic K ATP channel activity and to investigate potential mechanisms by which these isoforms specifically target these ion channels. We show that multiple PKC isoenzymes (α, β, δ, ε, θ and ι/ λ) coexist in rat aortic smooth muscle. These isozymes have been shown to differ in their cofactor requirement for activation, their subcellular localization and the intracellular proteins they phosphorylate [41, 42] . Such substrate specificity is apparent even amongst the family of K+ channel proteins. This and previous studies [9, 11] indicate that PKCε is involved in Ang II-induced inhibition of both K ATP and voltage-dependent K + (K v ) channels, while other reports show that PKCα mediates Ang II inhibition of inwardly rectifying K + (Kir) channels in coronary arterial cells [43] and PKCζ thromboxane-A 2 suppression of K v currents in the pulmonary artery [44] . Since PKC isozymes share considerable structural homology and demonstrate only poor substrate discrimination in in vitro assays it has been suggested that this in vivo specificity arises from differential targeting of activated PKC isoforms to distinct intracellular locations determined by the distribution of their substrate [22] [23] [24] . We have shown previously that vascular K ATP channels localize primarily to cholesterol-enriched invaginations of the plasma membrane termed caveolae [25] that are believed to form subcellular signalling 'pockets' by recruiting interacting signalling molecules [26] [27] [28] . These findings are supported by the present study where immunogold electron microscopy of aortic smooth muscle plasma membrane sheets confirms the presence of Kir6.1 in regions of the membrane morphologically identifiable as caveolae and which label with the caveolae-marker caveolin. To test the idea that PKC isoforms responsible for the modulation of K ATP channel activity are recruited to these membrane compartments, we isolated buoyant caveolar membranes from rat aortic smooth muscle cells under unstimulated control conditions and following exposure to Ang II. Western blot analysis revealed a significant shift in the distribution of PKCε to cholesterol-enriched fractions containing caveolin following exposure to Ang II. This Ang II-evoked migration of PKCε to caveolae was supported by immunogold TEM of Ang II-stimulated rat aortic smooth muscle cell membranes dual labelled with caveolin and PKCε. Thus, our findings indicate that PKC-dependent modulation of aortic K ATP channels by Ang II arises from the activation and translocation of PKCε to smooth muscle caveolae to allow PKCε access to K ATP channels compartmentalized within these specialized membrane domains.
Interestingly, our biochemical data suggest that Ang II also induces the translocation of PKCα to caveolae. Functionally, we find that only PKCε modulates aortic K ATP channel activity since the inhibitory effect of Ang II on pinacidil-evoked whole-cell K ATP currents persists in the presence of Gö6976, an inhibitor of the conventional PKC isoforms (α, β, γ), but is abolished by the selective PKCε translocation inhibitor peptide. One possible explanation for this is that PKCα and ε target separate populations of caveolae each containing a different compliment of signalling proteins. Only a proportion of caveolae would be expected to contain K ATP channel proteins, for example, since there are only a few hundred K ATP channels within the cell [45, 46] and an estimated 170 000 caveolae [47] . Selective targeting of a particular subset of caveolae by different PKC isozymes is an intriguing idea and could potentially work by different caveolae sequestering specific PKC targeting proteins. Proteins implicated in PKC targeting within cells include (i) substrates that interact with PKC (STICKs) such as annexins and multivalent kinase anchoring proteins (AKAP5/AKAP79, AKAP12/gravin); (ii) nonsubstrate targeting proteins (RACKs), and (iii) cytoskeletal or structural proteins such as caveolin [23, 24] . We have demonstrated previously the involvement of an unidentified AKAP in PKA-dependent activation of vascular K ATP channels [48] , indicating that these anchoring proteins may be responsible for the localization of kinases in the vicinity of the channel. Annexins are another targeting candidate, particularly since annexin II has recently been shown to associate in a Ca 2+ -dependent manner with cholesterol and sphingolipid-enriched regions of the membrane [49] . RACKs seem a less likely means by which PKC would target caveolae since we (unpublished observations) and others [30, 50] have shown that both RACK1 and RACK2 are largely excluded from caveolar membranes. Finally, structural proteins such as caveolins themselves may play a role in PKC targeting since caveolin isoforms have been shown to interact with many caveolae-localized signalling molecules, including selected PKC isozymes [51] [52] [53] and the pore-forming subunit of the K ATP channel [25] .
In conclusion, our data highlight a potential role for caveolae in vasoconstrictor-mediated targeting of specific PKC isoforms. Elevated plasma triglycerides and cholesterol, an essential component of caveolae, often accompany hypertension and alterations in membrane composition, fluidity and caveolar morphology have been reported in hypertensive humans and several animal models of hypertension [54, 55] . A more complete understanding of the physiological roles of these cholesterol-enriched microdomains may help explain some of the alterations in smooth muscle signalling and contractility seen in conditions such as hypercholesterolaemia [56, 57] .
